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Rationale. The study of common pathogenic mechanisms of comorbid course of ischemic heart 
disease (IHD) and acid related disorders (ARD) is an actual problem of modern medicine in terms of 
 prevention of cardiovascular complications. 
Aim of the study. To optimize the tactics of diagnosis and treatment of IHD when combined 
with the ARD of the gastrointestinal tract on a background of a long systemic intake of proton pump 
inhibitors (PPI). 
Material and methodsTo examine the effects of vitamin B supplementation on cardiovascular 
risk, we conducted a randomized study: 102 patients were examined, including 34 patients with 
isolated IHD, 33 patients with isolated ARD and 35 patients with comorbid pathology.  
Results.It was found that in patients with comorbid pathology were registered significantly 
lower levels of cyanocobalamin (237,1 ± 17,41 pg / ml) and higher levels of homocysteine (22,8 ± 
1.78 mmol / l) in blood plasma compared to the patients with isolated IHD (662,5±45,80 pg/ml; 
11,9±0,65 mmol/l, p<0.05). Hyperhomocysteinemia contributed to the development of atherogenic 
types dislipoproteinemia. Comorbidity for coronary heart disease and acid disorders accompanied by 
probable (p <0.05) increase in plasma levels of total cholesterol and low-density lipoproteins against 
decrease in high-density lipoproteins cholesterol levels compared to the isolated IHD (6.3%, 9.1% 
that 8.3%, respectively, p <0, 05). 
Тhe complex therapy that includes parenteral B12 supplementation leads to more effective 
correction of hyperhomocysteinaemia (26,1%, р<0,05) and dyslipidemia (total cholesterol - 14,9%, 
р<0,05; low-density lipoproteins - 22,3%, р<0,05), relative to the complex therapy without vitamin 
B12. 
Conclusion. Our results suggest that complex  ischemic heart disease therapy combined with 
vitamin B12 (but not vitamin B12 alone) may reduce serum lipids and hyperhomocysteinaemia in 
patients with comorbidity of IHD and ARD with long-term use of PPI.more effective. 
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Introduction. Sickness rate of obesity has been 57% increased in recent years, and it occurs in 
80% of endocrine patients. Prevalence of chronic pancreatitis (CP) in patients with obesity constitutes 
from 45% to 80%. 
Objective: to investigate the effect of L-carnitine on clinical manifestation of CP in patients 
with obesity. 
Materials and methods: 60 patients suffering from CP of a mixed etiology, painful form, 
relapsing course in the phase of a moderate exacerbation with I degree of obesity have been examined. 
To define the efficacy of treatment two representative groups were formed. The control group (1K) 
received low-calorie diet, anti-secretory (proton pump inhibitor), spasmolytic agents during 1 month, 
and polyenzymatic (kreon 10-20 000 UN), hypolipidic (atorvastatin 20-40 mg) medicines during 90 
days. The main group also received a drinkable L-carnitine (steatel) per 1,0 (10 ml) twice a day during 
90 days. 
Results of the study: analysis of the suggested therapy effect for the patients with CP (O group) 
on the course of the diseases compared to K group revealed improved general condition, reduced 
signs of asthenic-vegetative, intoxication syndromes, dyspeptic signs in patients of O group on the 4-
